China Foods Holdings Ltd. Annual Report - How They Did This Year

I’ve put together this guide to help you understand how China Foods Holdings Ltd. (CFOO) performed. My goal is to cut through the corporate jargon so you can decide if this company fits your portfolio.

1. What does this company do?

China Foods Holdings is a small participant in China’s $1.5 trillion "Great Health" industry. They act as a retailer and consultant for four main areas: meal replacements, health supplements, skincare, and imported French wine.

They use a "Consumer-to-Manufacturer" (C2M) model. They use data to identify consumer trends, then contract third-party factories to produce the goods. This "asset-light" approach means they avoid the overhead of owning factories, but it also means they rely entirely on outside suppliers for product quality and pricing.

2. Financial performance: The reality check

While the company describes this as a year of "steady growth," the financial results highlight the challenges of scaling their current model.

• Revenue is up: They generated $327,871 in 2025, a 40.5% increase from $233,339 in 2024.
• Costs are outpacing sales: Even with higher revenue, their gross profit dropped by 44.3%, falling from $53,873 in 2024 to $29,962 in 2025. This indicates that the cost of goods sold rose significantly faster than their sales, likely due to higher supplier prices or aggressive discounting.
• Ongoing losses: After accounting for operating expenses—such as office costs, professional fees, and marketing—the company reported a loss of $398,672 in 2025. While this is a 12.3% improvement over their 2024 loss, operating costs continue to significantly exceed their gross profit, requiring the company to rely on external capital or debt to fund operations.

3. Key risks to consider

Investing in this company involves specific hurdles that are important to weigh:

• Regulatory and Audit Risk: As an OTC Pink Sheets company, they are subject to U.S. audit requirements. Failure to allow regulators to inspect their books for two consecutive years could lead to removal from U.S. markets.
• Capital Movement: China maintains strict regulations regarding the transfer of funds out of the country. These rules can complicate the company’s ability to move capital to its U.S. parent entity for administrative or legal expenses.
• Market Competition: The company competes against major platforms like Alibaba and JD.com. These competitors possess vastly larger budgets and more sophisticated logistics networks, which makes it difficult for a smaller player like China Foods to capture significant market share.
• Legal Structure: The company operates in China while maintaining a U.S. listing through a complex corporate structure. In the event of a legal dispute, the protections available to foreign shareholders in Chinese courts may be limited.

4. Future outlook

Management is currently prioritizing a "digital-first" strategy, focusing on social media platforms like Douyin and WeChat to drive direct-to-consumer sales. They also intend to expand their skincare product line and establish partnerships with local fitness centers.

Given their current scale—including a physical office footprint of 43 square meters—the company’s future hinges on their ability to grow digital sales volume without further eroding their profit margins.

The Bottom Line: China Foods is a high-risk, speculative micro-cap. Their current financial trajectory shows they are spending significantly more to operate than they are bringing in through sales. Before considering an investment, ask yourself if you are comfortable with the risks of a company that is still struggling to find a path to profitability in a market dominated by much larger, better-funded competitors.